OBJECTIVE： To investigate the situation of blood glucose variation induced by chemotherapy drug， and to reflect the scientific research potential and influence of relative countries， institutions and medical research specialist staff. METHODS： All literatures which were published before Nov. 7， 2015， were retrieved from PubMed and CNKI， using “drug therapy”“blood glucose” and “chemotherapy” as keywords. English literatures were ranked in terms of country， city， journals， keyword， researcher， citation frequency， etc.， and then analyzed by bibliometrics； English literatures from China were ranked in terms of journals， cities， etc.， and then analyzed by bibliometrics； Chinese literatures were ranked in terms of institutions， citation times， etc. and then analyzed by bibliometrics. RESULTS： 11 445 literatures were retrieved from PubMed， involving 10 095 English papers （88.2％）； the most literatures were published in America （2 356 pieces）； there were 693 pieces of Chinese literatures， mainly from Beijing， Shanghai， Guangzhou and other cities. Most cited English papers focused on how to control blood glucose， while the most cited Chinese ones focused on the influenced blood glucose level. CONCLUSIONS： Literatures about chemotherapy drug inducing blood glucose variation are increasing year by year， and it is the hot point in clinical research. It is suggested to turn the research emphasis from merely observation into treatment.